Abstrakt

Przypisy

• 1. Abd Elhamid Elhamshary, Rabab Fawzy Salem Bayoumy and MohammedElsayed Abd Elnaby Nawaya: Circulating levels of inflammation-associatedmiR-155 and endothelial-enriched miR-126 inpatients with end-stage renal disease on regular haemodialysis. J.Am. Sci., 2015; 11: 165-169
  Google Scholar
• 2. Arroyo J.D, Chevillet J.R, Kroh E.M, Ruf I.K, Pritchard C.C, GibsonD.F, Mitchell P.S, Bennett C.F, Pogosova-Agadjanyan E.L, StirewaltD.L, Tait J.F, Tewari M.: Argonaute2 complexes carry a populationof circulating microRNAs independent of vesicles in human plasma.Proc. Natl. Acad. Sci. USA, 2011; 108: 5003-5008
  Google Scholar
• 3. Bartel D.P.: MicroRNAs: genomics, biogenesis, mechanism, andfunction. Cell, 2004; 116: 281-297
  Google Scholar
• 4. Brennecke J., Stark A., Russell R.B, Cohen S.M.: Principles of microRNA-targetrecognition. PLoS Biol., 2005; 3: e85: 0404-04018
  Google Scholar
• 5. Chen N.X., Kiattisunthorn K., O’Neill K.D, Chen X., Moorthi R.N.,Gattone V.H., Allen M.R., Moe S.M.: Decreased microRNA is involvedin the vascular remodeling abnormalities in chronic kidney disease(CKD). PLoS One, 2013; 8: e64558
  Google Scholar
• 6. Creemers E.E., Tijsen A.J., Pinto Y.M.: Circulating microRNAs:novel biomarkers and extracellular communicators in cardiovasculardisease? Circ. Res., 2012; 110: 483-495
  Google Scholar
• 7. Emilian C., Goretti E., Prospert F., Pouthier D., Duhoux P., GilsonG., Devaux Y., Wagner D.R.: MicroRNAs in patients on chronic hemodialysis(MINOS study). Clin. J. Am. Soc. Nephrol., 2012; 7: 619-623
  Google Scholar
• 8. Felekkis K., Touvana E., Stefanou Ch., Deltas C.: microRNAs: a newlydescribed class of encoded molecules that play a role in healthand disease. Hippokratia, 2010; 14: 236-240
  Google Scholar
• 9. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P.: Most mammalianmRNAs are conserved targets of microRNAs. Genome Res., 2009;19: 92-105
  Google Scholar
• 10. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y.: Chronickidney disease and the risks of death, cardiovascular events, andhospitalization. N. Engl. J. Med., 2004; 351: 1296-1305
  Google Scholar
• 11. Gupta S.K., Bang C., Thum T.: Circulating microRNAs as biomarkersand potential paracrine mediators of cardiovascular disease. Circ.Cardiovasc. Genet., 2010; 3: 484-488
  Google Scholar
• 12. Jackson R.J., Standart N.: How do microRNAs regulate gene expression?Sci. STKE, 2007; 2007: 1-13
  Google Scholar
• 13. Kidney Disease Outcomes Quality Initiative: K/DOQI clinicalpractice guidelines on hypertension and antihypertensive agents inchronic kidney disease. Am. J. Kidney Dis., 2004; 43, Suppl. 1: 11-13
  Google Scholar
• 14. Kosaka N., Iguchi H., Yoshioka Y., Takeshita F., Matsuki Y., OchiyaT.: Secretory mechanisms and intercellular transfer of microRNAsin living cells. J. Biol. Chem., 2010; 285: 17442-17452
  Google Scholar
• 15. Lorenzen J.M., Menne J., Schmidt B.M., Schmidt M., Martino F.,Dietrich R., Samiri S., Worthmann H., Heeren M., Weissenborn K.,Haller H., Schiffer M., Kielstein J.T., Thum T.: Circulating microRNAsin patients with Shiga-Toxin-producing E. coli O104:H4 induced hemolytic uremic syndrome. PLoS One, 2012; 7: e47215
  Google Scholar
• 16. Martino F., Lorenzen J., Schmidt J., Schmidt M., Broll M., GörzigY., Kielstein J.T., Thum T.: Circulating microRNAs are not eliminatedby hemodialysis. PLoS One, 2012; 7: e38269
  Google Scholar
• 17. Metzinger-Le Meuth V., M’Baya-Moutoula E., Taibi F., MassyZ., Metzinger L.: Implication of microRNAs in the pathophysiologyof cardiac and vascular smooth muscle cells. In: Current basic andpathological approaches to the function of muscle cells and tissues– from molecules to humans. Chapter 9, ed.: H. Sugi, InTech.,2012; 17: 183-206
  Google Scholar
• 18. Neal C.S., Michael M.Z., Pimlott L.K., Yong T.Y., Li J.Y., GleadleJ.M.: Circulating microRNA expression is reduced in chronic kidneydisease. Nephrol. Dial. Transplant., 2011; 26: 3794-3802
  Google Scholar
• 19. Pillai R.S., Bhattacharyya S.N., Filipowicz W.: Repression of proteinsynthesis by miRNAs: how many mechanisms? Trends Cell Biol.,2007; 17: 118-126
  Google Scholar
• 20. Sayed D., Abdellatif M.: MicroRNAs in development and disease.Physiol. Rev., 2011; 91: 827-887
  Google Scholar
• 21. Szeto C.C., Ching-Ha K.B., Ka-Bik L., Mac-Moune L.F., CheungLungC.P., Gang W., Kai-Ming C., Kam-Tao L.P.: Micro-RNA expressionin the urinary sediment of patients with chronic kidney diseases.Dis. Markers, 2012; 33: 137-144
  Google Scholar
• 22. Turchinovich A., Weiz L., Langheinz A., Burwinkel B.: Characterizationof extracellular circulating microRNA. Nucleic Acids Res.,2011; 39: 7223-7233
  Google Scholar
• 23. Wang H., Peng W., Shen X., Huang Y., Ouyang X., Dai Y.: Circulatinglevels of inflammation-associated miR-155 and endothelialenrichedmiR-126 in patients with end-stage renal disease. Braz. J.Med. Biol. Res., 2012; 45: 1308-1314
  Google Scholar
• 24. Wilflingseder J., Reindl-Schwaighofer R., Sunzenauer J., KainzA., Heinzel A., Mayer B., Oberbauer R.: MicroRNAs in kidney transplantation.Nephrol. Dial. Transplant., 2015; 30: 910-917
  Google Scholar
• 25. Zampetaki A., Willeit P., Drozdov I., Kiechl S., Mayr M.: Profilingof circulating microRNAs: from single biomarkers to re-wirednetworks. Cardiovasc. Res., 2012; 93: 555-562
  Google Scholar

Pełna treść artykułu